A trial of trientine in patients with hypertrophic cardiomyopathy

Registry ID

EUCTR2020-002242-17

Source registry

EUCTR

Status

GB - no longer in EU/EEA

Phase

PHASE2

Sponsor

Manchester University NHS Foundation Trust

Start date

2020-07-30

Last update

2026-08-16

Conditions

• Hypertrophic Cardiomyopathy (HCM)

Summary

To find out if trientine reduces heart muscle thickening in patients with hypertrophic cardiomyopathy.

Locations

• , , UK

Related clinical trials

• LA-HCM Study : Rivaroxaban for Antithrombotic Prevention in Hypertrophic Cardiomyopathy Patients With Abnormal Left Atrial Strain.
• Mavacamten to Aficamten Transition in Patients With Obstructive Hypertrophic Cardiomyopathy
• Multicentre Hypertrophic Cardiomyopathy Registry
• HCMR Re-Imaging Study
• Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases
• Retrospective Natural History Study of RASopathy-associated Cardiomyopathy (RAS-CM)

View on source registry